|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:PCCA-GRM3 (FusionGDB2 ID:63154) |
Fusion Gene Summary for PCCA-GRM3 |
Fusion gene summary |
Fusion gene information | Fusion gene name: PCCA-GRM3 | Fusion gene ID: 63154 | Hgene | Tgene | Gene symbol | PCCA | GRM3 | Gene ID | 5095 | 2913 |
Gene name | propionyl-CoA carboxylase subunit alpha | glutamate metabotropic receptor 3 | |
Synonyms | - | GLUR3|GPRC1C|MGLUR3|mGlu3 | |
Cytomap | 13q32.3 | 7q21.11-q21.12 | |
Type of gene | protein-coding | protein-coding | |
Description | propionyl-CoA carboxylase alpha chain, mitochondrialPCCase alpha subunitpccA complementation grouppropanoyl-CoA:carbon dioxide ligase alpha subunitpropionyl CoA carboxylase, alpha polypeptidepropionyl Coenzyme A carboxylase, alpha polypeptidepropion | metabotropic glutamate receptor 3glutamate receptor, metabotropic 3 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | Q14832 | |
Ensembl transtripts involved in fusion gene | ENST00000376285, ENST00000376286, ENST00000376279, ENST00000485946, | ENST00000394720, ENST00000439827, ENST00000536043, ENST00000546348, ENST00000361669, | |
Fusion gene scores | * DoF score | 20 X 16 X 12=3840 | 6 X 6 X 3=108 |
# samples | 25 | 6 | |
** MAII score | log2(25/3840*10)=-3.94110631094643 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(6/108*10)=-0.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: PCCA [Title/Abstract] AND GRM3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | PCCA(101167821)-GRM3(86415576), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene breakpoints across PCCA (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across GRM3 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | SARC | TCGA-SI-A71O | PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + |
Top |
Fusion Gene ORF analysis for PCCA-GRM3 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000376285 | ENST00000394720 | PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + |
5CDS-intron | ENST00000376285 | ENST00000439827 | PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + |
5CDS-intron | ENST00000376285 | ENST00000536043 | PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + |
5CDS-intron | ENST00000376285 | ENST00000546348 | PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + |
5CDS-intron | ENST00000376286 | ENST00000394720 | PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + |
5CDS-intron | ENST00000376286 | ENST00000439827 | PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + |
5CDS-intron | ENST00000376286 | ENST00000536043 | PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + |
5CDS-intron | ENST00000376286 | ENST00000546348 | PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + |
In-frame | ENST00000376285 | ENST00000361669 | PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + |
In-frame | ENST00000376286 | ENST00000361669 | PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + |
intron-3CDS | ENST00000376279 | ENST00000361669 | PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + |
intron-3CDS | ENST00000485946 | ENST00000361669 | PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + |
intron-intron | ENST00000376279 | ENST00000394720 | PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + |
intron-intron | ENST00000376279 | ENST00000439827 | PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + |
intron-intron | ENST00000376279 | ENST00000536043 | PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + |
intron-intron | ENST00000376279 | ENST00000546348 | PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + |
intron-intron | ENST00000485946 | ENST00000394720 | PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + |
intron-intron | ENST00000485946 | ENST00000439827 | PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + |
intron-intron | ENST00000485946 | ENST00000536043 | PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + |
intron-intron | ENST00000485946 | ENST00000546348 | PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000376286 | PCCA | chr13 | 101167821 | + | ENST00000361669 | GRM3 | chr7 | 86415576 | + | 4769 | 2068 | 64 | 4239 | 1391 |
ENST00000376285 | PCCA | chr13 | 101167821 | + | ENST00000361669 | GRM3 | chr7 | 86415576 | + | 4779 | 2078 | 38 | 4249 | 1403 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000376286 | ENST00000361669 | PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + | 0.000460648 | 0.9995394 |
ENST00000376285 | ENST00000361669 | PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + | 0.000351125 | 0.9996489 |
Top |
Fusion Genomic Features for PCCA-GRM3 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + | 0.00149731 | 0.99850273 |
PCCA | chr13 | 101167821 | + | GRM3 | chr7 | 86415576 | + | 0.00149731 | 0.99850273 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for PCCA-GRM3 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr13:101167821/chr7:86415576) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | GRM3 |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling inhibits adenylate cyclase activity. {ECO:0000269|PubMed:8840013}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PCCA | chr13:101167821 | chr7:86415576 | ENST00000376285 | + | 22 | 24 | 181_378 | 680 | 729.0 | Domain | ATP-grasp |
Hgene | PCCA | chr13:101167821 | chr7:86415576 | ENST00000376285 | + | 22 | 24 | 62_509 | 680 | 729.0 | Domain | Biotin carboxylation |
Hgene | PCCA | chr13:101167821 | chr7:86415576 | ENST00000376286 | + | 21 | 23 | 181_378 | 654 | 703.0 | Domain | ATP-grasp |
Hgene | PCCA | chr13:101167821 | chr7:86415576 | ENST00000376286 | + | 21 | 23 | 62_509 | 654 | 703.0 | Domain | Biotin carboxylation |
Hgene | PCCA | chr13:101167821 | chr7:86415576 | ENST00000376285 | + | 22 | 24 | 209_270 | 680 | 729.0 | Nucleotide binding | ATP |
Hgene | PCCA | chr13:101167821 | chr7:86415576 | ENST00000376286 | + | 21 | 23 | 209_270 | 654 | 703.0 | Nucleotide binding | ATP |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000361669 | 1 | 6 | 172_174 | 156 | 880.0 | Region | Glutamate binding | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000394720 | 1 | 5 | 172_174 | 154 | 536.0 | Region | Glutamate binding | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000439827 | 1 | 5 | 172_174 | 156 | 538.0 | Region | Glutamate binding | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000361669 | 1 | 6 | 600_613 | 156 | 880.0 | Topological domain | Cytoplasmic | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000361669 | 1 | 6 | 635_645 | 156 | 880.0 | Topological domain | Extracellular | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000361669 | 1 | 6 | 665_688 | 156 | 880.0 | Topological domain | Cytoplasmic | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000361669 | 1 | 6 | 710_734 | 156 | 880.0 | Topological domain | Extracellular | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000361669 | 1 | 6 | 757_769 | 156 | 880.0 | Topological domain | Cytoplasmic | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000361669 | 1 | 6 | 793_802 | 156 | 880.0 | Topological domain | Extracellular | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000361669 | 1 | 6 | 829_879 | 156 | 880.0 | Topological domain | Cytoplasmic | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000394720 | 1 | 5 | 600_613 | 154 | 536.0 | Topological domain | Cytoplasmic | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000394720 | 1 | 5 | 635_645 | 154 | 536.0 | Topological domain | Extracellular | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000394720 | 1 | 5 | 665_688 | 154 | 536.0 | Topological domain | Cytoplasmic | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000394720 | 1 | 5 | 710_734 | 154 | 536.0 | Topological domain | Extracellular | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000394720 | 1 | 5 | 757_769 | 154 | 536.0 | Topological domain | Cytoplasmic | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000394720 | 1 | 5 | 793_802 | 154 | 536.0 | Topological domain | Extracellular | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000394720 | 1 | 5 | 829_879 | 154 | 536.0 | Topological domain | Cytoplasmic | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000439827 | 1 | 5 | 600_613 | 156 | 538.0 | Topological domain | Cytoplasmic | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000439827 | 1 | 5 | 635_645 | 156 | 538.0 | Topological domain | Extracellular | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000439827 | 1 | 5 | 665_688 | 156 | 538.0 | Topological domain | Cytoplasmic | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000439827 | 1 | 5 | 710_734 | 156 | 538.0 | Topological domain | Extracellular | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000439827 | 1 | 5 | 757_769 | 156 | 538.0 | Topological domain | Cytoplasmic | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000439827 | 1 | 5 | 793_802 | 156 | 538.0 | Topological domain | Extracellular | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000439827 | 1 | 5 | 829_879 | 156 | 538.0 | Topological domain | Cytoplasmic | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000361669 | 1 | 6 | 577_599 | 156 | 880.0 | Transmembrane | Helical%3B Name%3D1 | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000361669 | 1 | 6 | 614_634 | 156 | 880.0 | Transmembrane | Helical%3B Name%3D2 | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000361669 | 1 | 6 | 646_664 | 156 | 880.0 | Transmembrane | Helical%3B Name%3D3 | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000361669 | 1 | 6 | 689_709 | 156 | 880.0 | Transmembrane | Helical%3B Name%3D4 | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000361669 | 1 | 6 | 735_756 | 156 | 880.0 | Transmembrane | Helical%3B Name%3D5 | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000361669 | 1 | 6 | 770_792 | 156 | 880.0 | Transmembrane | Helical%3B Name%3D6 | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000361669 | 1 | 6 | 803_828 | 156 | 880.0 | Transmembrane | Helical%3B Name%3D7 | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000394720 | 1 | 5 | 577_599 | 154 | 536.0 | Transmembrane | Helical%3B Name%3D1 | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000394720 | 1 | 5 | 614_634 | 154 | 536.0 | Transmembrane | Helical%3B Name%3D2 | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000394720 | 1 | 5 | 646_664 | 154 | 536.0 | Transmembrane | Helical%3B Name%3D3 | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000394720 | 1 | 5 | 689_709 | 154 | 536.0 | Transmembrane | Helical%3B Name%3D4 | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000394720 | 1 | 5 | 735_756 | 154 | 536.0 | Transmembrane | Helical%3B Name%3D5 | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000394720 | 1 | 5 | 770_792 | 154 | 536.0 | Transmembrane | Helical%3B Name%3D6 | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000394720 | 1 | 5 | 803_828 | 154 | 536.0 | Transmembrane | Helical%3B Name%3D7 | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000439827 | 1 | 5 | 577_599 | 156 | 538.0 | Transmembrane | Helical%3B Name%3D1 | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000439827 | 1 | 5 | 614_634 | 156 | 538.0 | Transmembrane | Helical%3B Name%3D2 | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000439827 | 1 | 5 | 646_664 | 156 | 538.0 | Transmembrane | Helical%3B Name%3D3 | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000439827 | 1 | 5 | 689_709 | 156 | 538.0 | Transmembrane | Helical%3B Name%3D4 | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000439827 | 1 | 5 | 735_756 | 156 | 538.0 | Transmembrane | Helical%3B Name%3D5 | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000439827 | 1 | 5 | 770_792 | 156 | 538.0 | Transmembrane | Helical%3B Name%3D6 | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000439827 | 1 | 5 | 803_828 | 156 | 538.0 | Transmembrane | Helical%3B Name%3D7 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PCCA | chr13:101167821 | chr7:86415576 | ENST00000376279 | + | 1 | 23 | 181_378 | 0 | 682.0 | Domain | ATP-grasp |
Hgene | PCCA | chr13:101167821 | chr7:86415576 | ENST00000376279 | + | 1 | 23 | 62_509 | 0 | 682.0 | Domain | Biotin carboxylation |
Hgene | PCCA | chr13:101167821 | chr7:86415576 | ENST00000376279 | + | 1 | 23 | 653_728 | 0 | 682.0 | Domain | Biotinyl-binding |
Hgene | PCCA | chr13:101167821 | chr7:86415576 | ENST00000376285 | + | 22 | 24 | 653_728 | 680 | 729.0 | Domain | Biotinyl-binding |
Hgene | PCCA | chr13:101167821 | chr7:86415576 | ENST00000376286 | + | 21 | 23 | 653_728 | 654 | 703.0 | Domain | Biotinyl-binding |
Hgene | PCCA | chr13:101167821 | chr7:86415576 | ENST00000376279 | + | 1 | 23 | 209_270 | 0 | 682.0 | Nucleotide binding | ATP |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000361669 | 1 | 6 | 23_576 | 156 | 880.0 | Topological domain | Extracellular | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000394720 | 1 | 5 | 23_576 | 154 | 536.0 | Topological domain | Extracellular | |
Tgene | GRM3 | chr13:101167821 | chr7:86415576 | ENST00000439827 | 1 | 5 | 23_576 | 156 | 538.0 | Topological domain | Extracellular |
Top |
Fusion Gene Sequence for PCCA-GRM3 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>63154_63154_1_PCCA-GRM3_PCCA_chr13_101167821_ENST00000376285_GRM3_chr7_86415576_ENST00000361669_length(transcript)=4779nt_BP=2078nt GTGAGAGGTCAGCAGAGGGGCGGTCTGCGGGGACAACAATGGCGGGGTTCTGGGTCGGGACAGCACCGCTGGTCGCTGCCGGACGGCGTG GGCGGTGGCCGCCGCAGCAGCTGATGCTGAGCGCGGCGCTGCGGACCCTGAAGCATGTTCTGTACTATTCAAGACAGTGCTTAATGGTGT CCCGTAATCTTGGTTCAGTGGGATATGATCCTAATGAAAAAACTTTTGATAAAATTCTTGTTGCTAATAGAGGAGAAATTGCATGTCGGG TTATTAGAACTTGCAAGAAGATGGGCATTAAGACAGTTGCCATCCACAGTGATGTTGATGCTAGTTCTGTTCATGTGAAAATGGCGGATG AGGCTGTCTGTGTTGGCCCAGCTCCCACCAGTAAAAGCTACCTCAACATGGATGCCATCATGGAAGCCATTAAGAAAACCAGGGCCCAAG CTGTACATCCAGGTTATGGATTCCTTTCAGAAAACAAAGAATTTGCCAGATGTTTGGCAGCAGAAGATGTCGTTTTCATTGGACCTGACA CACATGCTATTCAAGCCATGGGCGACAAGATTGAAAGCAAATTATTAGCTAAGAAAGCAGAGGTTAATACAATCCCTGGCTTTGATGGAG TAGTCAAGGATGCAGAAGAAGCTGTCAGAATTGCAAGGGAAATTGGCTACCCTGTCATGATCAAGGCCTCAGCAGGTGGTGGTGGGAAAG GCATGCGCATTGCTTGGGATGATGAAGAGACCAGGGATGGTTTTAGATTGTCATCTCAAGAAGCTGCTTCTAGTTTTGGCGATGATAGAC TACTAATAGAAAAATTTATTGATAATCCTCGTCATATAGAAATCCAGGTTCTAGGTGATAAACATGGGAATGCTTTATGGCTTAATGAAA GAGAGTGCTCAATTCAGAGAAGAAATCAGAAGGTGGTGGAGGAAGCACCAAGCATTTTTTTGGATGCGGAGACTCGAAGAGCGATGGGAG AACAAGCTGTAGCTCTTGCCAGAGCAGTAAAATATTCCTCTGCTGGGACCGTGGAGTTCCTTGTGGACTCTAAGAAGAATTTTTATTTCT TGGAAATGAATACAAGACTCCAGGTTGAGCATCCTGTCACAGAATGCATTACTGGCCTGGACCTAGTCCAGGAAATGATCCGTGTTGCTA AGGGCTACCCTCTCAGGCACAAACAAGCTGATATTCGCATCAACGGCTGGGCAGTTGAATGTCGGGTTTATGCTGAGGACCCCTACAAGT CTTTTGGTTTACCATCTATTGGGAGATTGTCTCAGTACCAAGAACCGTTACATCTACCTGGTGTCCGAGTGGACAGTGGCATCCAACCAG GAAGTGATATTAGCATTTATTATGATCCTATGATTTCAAAACTAATCACATATGGCTCTGATAGAACTGAGGCACTGAAGAGAATGGCAG ATGCACTGGATAACTATGTTATTCGAGGTGTTACACATAATATTGCATTACTTCGAGAGGTGATAATCAACTCACGCTTTGTAAAAGGAG ACATCAGCACTAAATTTCTCTCCGATGTGTATCCTGATGGCTTCAAAGGACACATGCTAACCAAGAGTGAGAAGAACCAGTTATTGGCAA TAGCATCATCATTGTTTGTGGCATTCCAGTTAAGAGCACAACATTTTCAAGAAAATTCAAGAATGCCTGTTATTAAACCAGACATAGCCA ACTGGGAGCTCTCAGTAAAATTGCATGATAAAGTTCATACCGTAGTAGCATCAAACAATGGGTCAGTGTTCTCGGTGGAAGTTGATGGGT CGAAACTAAATGTGACCAGCACGTGGAACCTGGCTTCGCCCTTATTGTCTGTCAGCGTTGATGGCACTCAGAGGACTGTCCAGTGTCTTT CTCGAGAAGCAGGTGGAAACATGAGCATTCAGTTTCTTGGTACAGTGTACAAGGTGAATATCTTAACCAGACTTGCCGCAGAATTGAACA AATTTATGCTGGAAAAAGTGACTGAGGACACAAGCAGTGTTCTGCGTTCCCCGATGCCCGGAGTGGTGGTGGCCGTCTCTGTCAAGCCTG GAGACGCGGTGGCAAACCTGCTGCGGCTCTTCCAGATCCCTCAGATCAGCTACGCATCCACCAGCGCCAAACTCAGTGATAAGTCGCGCT ATGATTACTTTGCCAGGACCGTGCCCCCCGACTTCTACCAGGCCAAAGCCATGGCTGAGATCTTGCGCTTCTTCAACTGGACCTACGTGT CCACAGTAGCCTCCGAGGGTGATTACGGGGAGACAGGGATCGAGGCCTTCGAGCAGGAAGCCCGCCTGCGCAACATCTGCATCGCTACGG CGGAGAAGGTGGGCCGCTCCAACATCCGCAAGTCCTACGACAGCGTGATCCGAGAACTGTTGCAGAAGCCCAACGCGCGCGTCGTGGTCC TCTTCATGCGCAGCGACGACTCGCGGGAGCTCATTGCAGCCGCCAGCCGCGCCAATGCCTCCTTCACCTGGGTGGCCAGCGACGGCTGGG GCGCGCAGGAGAGCATCATCAAGGGCAGCGAGCATGTGGCCTACGGCGCCATCACCCTGGAGCTGGCCTCCCAGCCTGTCCGCCAGTTCG ACCGCTACTTCCAGAGCCTCAACCCCTACAACAACCACCGCAACCCCTGGTTCCGGGACTTCTGGGAGCAAAAGTTTCAGTGCAGCCTCC AGAACAAACGCAACCACAGGCGCGTCTGCGACAAGCACCTGGCCATCGACAGCAGCAACTACGAGCAAGAGTCCAAGATCATGTTTGTGG TGAACGCGGTGTATGCCATGGCCCACGCTTTGCACAAAATGCAGCGCACCCTCTGTCCCAACACTACCAAGCTTTGTGATGCTATGAAGA TCCTGGATGGGAAGAAGTTGTACAAGGATTACTTGCTGAAAATCAACTTCACGGCTCCATTCAACCCAAATAAAGATGCAGATAGCATAG TCAAGTTTGACACTTTTGGAGATGGAATGGGGCGATACAACGTGTTCAATTTCCAAAATGTAGGTGGAAAGTATTCCTACTTGAAAGTTG GTCACTGGGCAGAAACCTTATCGCTAGATGTCAACTCTATCCACTGGTCCCGGAACTCAGTCCCCACTTCCCAGTGCAGCGACCCCTGTG CCCCCAATGAAATGAAGAATATGCAACCAGGGGATGTCTGCTGCTGGATTTGCATCCCCTGTGAACCCTACGAATACCTGGCTGATGAGT TTACCTGTATGGATTGTGGGTCTGGACAGTGGCCCACTGCAGACCTAACTGGATGCTATGACCTTCCTGAGGACTACATCAGGTGGGAAG ACGCCTGGGCCATTGGCCCAGTCACCATTGCCTGTCTGGGTTTTATGTGTACATGCATGGTTGTAACTGTTTTTATCAAGCACAACAACA CACCCTTGGTCAAAGCATCGGGCCGAGAACTCTGCTACATCTTATTGTTTGGGGTTGGCCTGTCATACTGCATGACATTCTTCTTCATTG CCAAGCCATCACCAGTCATCTGTGCATTGCGCCGACTCGGGCTGGGGAGTTCCTTCGCTATCTGTTACTCAGCCCTGCTGACCAAGACAA ACTGCATTGCCCGCATCTTCGATGGGGTCAAGAATGGCGCTCAGAGGCCAAAATTCATCAGCCCCAGTTCTCAGGTTTTCATCTGCCTGG GTCTGATCCTGGTGCAAATTGTGATGGTGTCTGTGTGGCTCATCCTGGAGGCCCCAGGCACCAGGAGGTATACCCTTGCAGAGAAGCGGG AAACAGTCATCCTAAAATGCAATGTCAAAGATTCCAGCATGTTGATCTCTCTTACCTACGATGTGATCCTGGTGATCTTATGCACTGTGT ACGCCTTCAAAACGCGGAAGTGCCCAGAAAATTTCAACGAAGCTAAGTTCATAGGTTTTACCATGTACACCACGTGCATCATCTGGTTGG CCTTCCTCCCTATATTTTATGTGACATCAAGTGACTACAGAGTGCAGACGACAACCATGTGCATCTCTGTCAGCCTGAGTGGCTTTGTGG TCTTGGGCTGTTTGTTTGCACCCAAGGTTCACATCATCCTGTTTCAACCCCAGAAGAATGTTGTCACACACAGACTGCACCTCAACAGGT TCAGTGTCAGTGGAACTGGGACCACATACTCTCAGTCCTCTGCAAGCACGTATGTGCCAACGGTGTGCAATGGGCGGGAAGTCCTCGACT CCACCACCTCATCTCTGTGATTGTGAATTGCAGTTCAGTTCTTGTGTTTTTAGACTGTTAGACAAAAGTGCTCACGTGCAGCTCCAGAAT ATGGAAACAGAGCAAAAGAACAACCCTAGTACCTTTTTTTAGAAACAGTACGATAAATTATTTTTGAGGACTGTATATAGTGATGTGCTA GAACTTTCTAGGCTGAGTCTAGTGCCCCTATTATTAACAATTCCCCCAGAACATGGAAATAACCATTGTTTACAGAGCTGAGCATTGGTG ACAGGGTCTGACATGGTCAGTCTACTAAAAAACAAAAAAAAAAAACAAAAAAAAAAAAACAAAAGAAAAAAATAAAAATACGGTGGCAAT ATTATGTAACCTTTTTTCCTATGAAGTTTTTTGTAGGTCCTTGTTGTAACTAATTTAGGATGAGTTTCTATGTTGTATATTAAAGTTACA TTATGTGTAACAGATTGATTTTCTCAGCACAAAATAAAAAGCATCTGTATTAATGTAAAGATACTGAGAATAAAACCTTCAAGGTTTTCC >63154_63154_1_PCCA-GRM3_PCCA_chr13_101167821_ENST00000376285_GRM3_chr7_86415576_ENST00000361669_length(amino acids)=1403AA_BP=680 MAGFWVGTAPLVAAGRRGRWPPQQLMLSAALRTLKHVLYYSRQCLMVSRNLGSVGYDPNEKTFDKILVANRGEIACRVIRTCKKMGIKTV AIHSDVDASSVHVKMADEAVCVGPAPTSKSYLNMDAIMEAIKKTRAQAVHPGYGFLSENKEFARCLAAEDVVFIGPDTHAIQAMGDKIES KLLAKKAEVNTIPGFDGVVKDAEEAVRIAREIGYPVMIKASAGGGGKGMRIAWDDEETRDGFRLSSQEAASSFGDDRLLIEKFIDNPRHI EIQVLGDKHGNALWLNERECSIQRRNQKVVEEAPSIFLDAETRRAMGEQAVALARAVKYSSAGTVEFLVDSKKNFYFLEMNTRLQVEHPV TECITGLDLVQEMIRVAKGYPLRHKQADIRINGWAVECRVYAEDPYKSFGLPSIGRLSQYQEPLHLPGVRVDSGIQPGSDISIYYDPMIS KLITYGSDRTEALKRMADALDNYVIRGVTHNIALLREVIINSRFVKGDISTKFLSDVYPDGFKGHMLTKSEKNQLLAIASSLFVAFQLRA QHFQENSRMPVIKPDIANWELSVKLHDKVHTVVASNNGSVFSVEVDGSKLNVTSTWNLASPLLSVSVDGTQRTVQCLSREAGGNMSIQFL GTVYKVNILTRLAAELNKFMLEKVTEDTSSVLRSPMPGVVVAVSVKPGDAVANLLRLFQIPQISYASTSAKLSDKSRYDYFARTVPPDFY QAKAMAEILRFFNWTYVSTVASEGDYGETGIEAFEQEARLRNICIATAEKVGRSNIRKSYDSVIRELLQKPNARVVVLFMRSDDSRELIA AASRANASFTWVASDGWGAQESIIKGSEHVAYGAITLELASQPVRQFDRYFQSLNPYNNHRNPWFRDFWEQKFQCSLQNKRNHRRVCDKH LAIDSSNYEQESKIMFVVNAVYAMAHALHKMQRTLCPNTTKLCDAMKILDGKKLYKDYLLKINFTAPFNPNKDADSIVKFDTFGDGMGRY NVFNFQNVGGKYSYLKVGHWAETLSLDVNSIHWSRNSVPTSQCSDPCAPNEMKNMQPGDVCCWICIPCEPYEYLADEFTCMDCGSGQWPT ADLTGCYDLPEDYIRWEDAWAIGPVTIACLGFMCTCMVVTVFIKHNNTPLVKASGRELCYILLFGVGLSYCMTFFFIAKPSPVICALRRL GLGSSFAICYSALLTKTNCIARIFDGVKNGAQRPKFISPSSQVFICLGLILVQIVMVSVWLILEAPGTRRYTLAEKRETVILKCNVKDSS MLISLTYDVILVILCTVYAFKTRKCPENFNEAKFIGFTMYTTCIIWLAFLPIFYVTSSDYRVQTTTMCISVSLSGFVVLGCLFAPKVHII -------------------------------------------------------------- >63154_63154_2_PCCA-GRM3_PCCA_chr13_101167821_ENST00000376286_GRM3_chr7_86415576_ENST00000361669_length(transcript)=4769nt_BP=2068nt GGCATCGGGTTTCTGGCTCGTGATTTGCCGGAGCTCCTGCGCTCCCCTTCTCCACCCCCTCCGGCTGTGTGAGAGGTCAGCAGAGGGGCG GTCTGCGGGGACAACAATGGCGGGGTTCTGGGTCGGGACAGCACCGCTGGTCGCTGCCGGACGGCGTGGGCGGTGGCCGCCGCAGCAGCT GATGCTGAGCGCGGCGCTGCGGACCCTGAAGACTTTTGATAAAATTCTTGTTGCTAATAGAGGAGAAATTGCATGTCGGGTTATTAGAAC TTGCAAGAAGATGGGCATTAAGACAGTTGCCATCCACAGTGATGTTGATGCTAGTTCTGTTCATGTGAAAATGGCGGATGAGGCTGTCTG TGTTGGCCCAGCTCCCACCAGTAAAAGCTACCTCAACATGGATGCCATCATGGAAGCCATTAAGAAAACCAGGGCCCAAGCTGTACATCC AGGTTATGGATTCCTTTCAGAAAACAAAGAATTTGCCAGATGTTTGGCAGCAGAAGATGTCGTTTTCATTGGACCTGACACACATGCTAT TCAAGCCATGGGCGACAAGATTGAAAGCAAATTATTAGCTAAGAAAGCAGAGGTTAATACAATCCCTGGCTTTGATGGAGTAGTCAAGGA TGCAGAAGAAGCTGTCAGAATTGCAAGGGAAATTGGCTACCCTGTCATGATCAAGGCCTCAGCAGGTGGTGGTGGGAAAGGCATGCGCAT TGCTTGGGATGATGAAGAGACCAGGGATGGTTTTAGATTGTCATCTCAAGAAGCTGCTTCTAGTTTTGGCGATGATAGACTACTAATAGA AAAATTTATTGATAATCCTCGTCATATAGAAATCCAGGTTCTAGGTGATAAACATGGGAATGCTTTATGGCTTAATGAAAGAGAGTGCTC AATTCAGAGAAGAAATCAGAAGGTGGTGGAGGAAGCACCAAGCATTTTTTTGGATGCGGAGACTCGAAGAGCGATGGGAGAACAAGCTGT AGCTCTTGCCAGAGCAGTAAAATATTCCTCTGCTGGGACCGTGGAGTTCCTTGTGGACTCTAAGAAGAATTTTTATTTCTTGGAAATGAA TACAAGACTCCAGGTTGAGCATCCTGTCACAGAATGCATTACTGGCCTGGACCTAGTCCAGGAAATGATCCGTGTTGCTAAGGGCTACCC TCTCAGGCACAAACAAGCTGATATTCGCATCAACGGCTGGGCAGTTGAATGTCGGGTTTATGCTGAGGACCCCTACAAGTCTTTTGGTTT ACCATCTATTGGGAGATTGTCTCAGTACCAAGAACCGTTACATCTACCTGGTGTCCGAGTGGACAGTGGCATCCAACCAGGAAGTGATAT TAGCATTTATTATGATCCTATGATTTCAAAACTAATCACATATGGCTCTGATAGAACTGAGGCACTGAAGAGAATGGCAGATGCACTGGA TAACTATGTTATTCGAGGTGTTACACATAATATTGCATTACTTCGAGAGGTGATAATCAACTCACGCTTTGTAAAAGGAGACATCAGCAC TAAATTTCTCTCCGATGTGTATCCTGATGGCTTCAAAGGACACATGCTAACCAAGAGTGAGAAGAACCAGTTATTGGCAATAGCATCATC ATTGTTTGTGGCATTCCAGTTAAGAGCACAACATTTTCAAGAAAATTCAAGAATGCCTGTTATTAAACCAGACATAGCCAACTGGGAGCT CTCAGTAAAATTGCATGATAAAGTTCATACCGTAGTAGCATCAAACAATGGGTCAGTGTTCTCGGTGGAAGTTGATGGGTCGAAACTAAA TGTGACCAGCACGTGGAACCTGGCTTCGCCCTTATTGTCTGTCAGCGTTGATGGCACTCAGAGGACTGTCCAGTGTCTTTCTCGAGAAGC AGGTGGAAACATGAGCATTCAGTTTCTTGGTACAGTGTACAAGGTGAATATCTTAACCAGACTTGCCGCAGAATTGAACAAATTTATGCT GGAAAAAGTGACTGAGGACACAAGCAGTGTTCTGCGTTCCCCGATGCCCGGAGTGGTGGTGGCCGTCTCTGTCAAGCCTGGAGACGCGGT GGCAAACCTGCTGCGGCTCTTCCAGATCCCTCAGATCAGCTACGCATCCACCAGCGCCAAACTCAGTGATAAGTCGCGCTATGATTACTT TGCCAGGACCGTGCCCCCCGACTTCTACCAGGCCAAAGCCATGGCTGAGATCTTGCGCTTCTTCAACTGGACCTACGTGTCCACAGTAGC CTCCGAGGGTGATTACGGGGAGACAGGGATCGAGGCCTTCGAGCAGGAAGCCCGCCTGCGCAACATCTGCATCGCTACGGCGGAGAAGGT GGGCCGCTCCAACATCCGCAAGTCCTACGACAGCGTGATCCGAGAACTGTTGCAGAAGCCCAACGCGCGCGTCGTGGTCCTCTTCATGCG CAGCGACGACTCGCGGGAGCTCATTGCAGCCGCCAGCCGCGCCAATGCCTCCTTCACCTGGGTGGCCAGCGACGGCTGGGGCGCGCAGGA GAGCATCATCAAGGGCAGCGAGCATGTGGCCTACGGCGCCATCACCCTGGAGCTGGCCTCCCAGCCTGTCCGCCAGTTCGACCGCTACTT CCAGAGCCTCAACCCCTACAACAACCACCGCAACCCCTGGTTCCGGGACTTCTGGGAGCAAAAGTTTCAGTGCAGCCTCCAGAACAAACG CAACCACAGGCGCGTCTGCGACAAGCACCTGGCCATCGACAGCAGCAACTACGAGCAAGAGTCCAAGATCATGTTTGTGGTGAACGCGGT GTATGCCATGGCCCACGCTTTGCACAAAATGCAGCGCACCCTCTGTCCCAACACTACCAAGCTTTGTGATGCTATGAAGATCCTGGATGG GAAGAAGTTGTACAAGGATTACTTGCTGAAAATCAACTTCACGGCTCCATTCAACCCAAATAAAGATGCAGATAGCATAGTCAAGTTTGA CACTTTTGGAGATGGAATGGGGCGATACAACGTGTTCAATTTCCAAAATGTAGGTGGAAAGTATTCCTACTTGAAAGTTGGTCACTGGGC AGAAACCTTATCGCTAGATGTCAACTCTATCCACTGGTCCCGGAACTCAGTCCCCACTTCCCAGTGCAGCGACCCCTGTGCCCCCAATGA AATGAAGAATATGCAACCAGGGGATGTCTGCTGCTGGATTTGCATCCCCTGTGAACCCTACGAATACCTGGCTGATGAGTTTACCTGTAT GGATTGTGGGTCTGGACAGTGGCCCACTGCAGACCTAACTGGATGCTATGACCTTCCTGAGGACTACATCAGGTGGGAAGACGCCTGGGC CATTGGCCCAGTCACCATTGCCTGTCTGGGTTTTATGTGTACATGCATGGTTGTAACTGTTTTTATCAAGCACAACAACACACCCTTGGT CAAAGCATCGGGCCGAGAACTCTGCTACATCTTATTGTTTGGGGTTGGCCTGTCATACTGCATGACATTCTTCTTCATTGCCAAGCCATC ACCAGTCATCTGTGCATTGCGCCGACTCGGGCTGGGGAGTTCCTTCGCTATCTGTTACTCAGCCCTGCTGACCAAGACAAACTGCATTGC CCGCATCTTCGATGGGGTCAAGAATGGCGCTCAGAGGCCAAAATTCATCAGCCCCAGTTCTCAGGTTTTCATCTGCCTGGGTCTGATCCT GGTGCAAATTGTGATGGTGTCTGTGTGGCTCATCCTGGAGGCCCCAGGCACCAGGAGGTATACCCTTGCAGAGAAGCGGGAAACAGTCAT CCTAAAATGCAATGTCAAAGATTCCAGCATGTTGATCTCTCTTACCTACGATGTGATCCTGGTGATCTTATGCACTGTGTACGCCTTCAA AACGCGGAAGTGCCCAGAAAATTTCAACGAAGCTAAGTTCATAGGTTTTACCATGTACACCACGTGCATCATCTGGTTGGCCTTCCTCCC TATATTTTATGTGACATCAAGTGACTACAGAGTGCAGACGACAACCATGTGCATCTCTGTCAGCCTGAGTGGCTTTGTGGTCTTGGGCTG TTTGTTTGCACCCAAGGTTCACATCATCCTGTTTCAACCCCAGAAGAATGTTGTCACACACAGACTGCACCTCAACAGGTTCAGTGTCAG TGGAACTGGGACCACATACTCTCAGTCCTCTGCAAGCACGTATGTGCCAACGGTGTGCAATGGGCGGGAAGTCCTCGACTCCACCACCTC ATCTCTGTGATTGTGAATTGCAGTTCAGTTCTTGTGTTTTTAGACTGTTAGACAAAAGTGCTCACGTGCAGCTCCAGAATATGGAAACAG AGCAAAAGAACAACCCTAGTACCTTTTTTTAGAAACAGTACGATAAATTATTTTTGAGGACTGTATATAGTGATGTGCTAGAACTTTCTA GGCTGAGTCTAGTGCCCCTATTATTAACAATTCCCCCAGAACATGGAAATAACCATTGTTTACAGAGCTGAGCATTGGTGACAGGGTCTG ACATGGTCAGTCTACTAAAAAACAAAAAAAAAAAACAAAAAAAAAAAAACAAAAGAAAAAAATAAAAATACGGTGGCAATATTATGTAAC CTTTTTTCCTATGAAGTTTTTTGTAGGTCCTTGTTGTAACTAATTTAGGATGAGTTTCTATGTTGTATATTAAAGTTACATTATGTGTAA >63154_63154_2_PCCA-GRM3_PCCA_chr13_101167821_ENST00000376286_GRM3_chr7_86415576_ENST00000361669_length(amino acids)=1391AA_BP=668 MCERSAEGRSAGTTMAGFWVGTAPLVAAGRRGRWPPQQLMLSAALRTLKTFDKILVANRGEIACRVIRTCKKMGIKTVAIHSDVDASSVH VKMADEAVCVGPAPTSKSYLNMDAIMEAIKKTRAQAVHPGYGFLSENKEFARCLAAEDVVFIGPDTHAIQAMGDKIESKLLAKKAEVNTI PGFDGVVKDAEEAVRIAREIGYPVMIKASAGGGGKGMRIAWDDEETRDGFRLSSQEAASSFGDDRLLIEKFIDNPRHIEIQVLGDKHGNA LWLNERECSIQRRNQKVVEEAPSIFLDAETRRAMGEQAVALARAVKYSSAGTVEFLVDSKKNFYFLEMNTRLQVEHPVTECITGLDLVQE MIRVAKGYPLRHKQADIRINGWAVECRVYAEDPYKSFGLPSIGRLSQYQEPLHLPGVRVDSGIQPGSDISIYYDPMISKLITYGSDRTEA LKRMADALDNYVIRGVTHNIALLREVIINSRFVKGDISTKFLSDVYPDGFKGHMLTKSEKNQLLAIASSLFVAFQLRAQHFQENSRMPVI KPDIANWELSVKLHDKVHTVVASNNGSVFSVEVDGSKLNVTSTWNLASPLLSVSVDGTQRTVQCLSREAGGNMSIQFLGTVYKVNILTRL AAELNKFMLEKVTEDTSSVLRSPMPGVVVAVSVKPGDAVANLLRLFQIPQISYASTSAKLSDKSRYDYFARTVPPDFYQAKAMAEILRFF NWTYVSTVASEGDYGETGIEAFEQEARLRNICIATAEKVGRSNIRKSYDSVIRELLQKPNARVVVLFMRSDDSRELIAAASRANASFTWV ASDGWGAQESIIKGSEHVAYGAITLELASQPVRQFDRYFQSLNPYNNHRNPWFRDFWEQKFQCSLQNKRNHRRVCDKHLAIDSSNYEQES KIMFVVNAVYAMAHALHKMQRTLCPNTTKLCDAMKILDGKKLYKDYLLKINFTAPFNPNKDADSIVKFDTFGDGMGRYNVFNFQNVGGKY SYLKVGHWAETLSLDVNSIHWSRNSVPTSQCSDPCAPNEMKNMQPGDVCCWICIPCEPYEYLADEFTCMDCGSGQWPTADLTGCYDLPED YIRWEDAWAIGPVTIACLGFMCTCMVVTVFIKHNNTPLVKASGRELCYILLFGVGLSYCMTFFFIAKPSPVICALRRLGLGSSFAICYSA LLTKTNCIARIFDGVKNGAQRPKFISPSSQVFICLGLILVQIVMVSVWLILEAPGTRRYTLAEKRETVILKCNVKDSSMLISLTYDVILV ILCTVYAFKTRKCPENFNEAKFIGFTMYTTCIIWLAFLPIFYVTSSDYRVQTTTMCISVSLSGFVVLGCLFAPKVHIILFQPQKNVVTHR -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for PCCA-GRM3 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for PCCA-GRM3 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for PCCA-GRM3 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |